| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,270 | 4,401 | 10,192 | 14,306 | | Cost of Revenue | 2,029 | 1,691 | 1,594 | 5,772 | | | Gross Profit | 5,241 | 2,710 | 8,598 | 8,534 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,022 | 10,942 | 11,799 | 14,388 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,438 | 1,066 | 1,191 | 6,310 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,219) | (9,298) | (4,392) | (12,164) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 107 | (6,913) | 312 | (7,208) | | Earnings Before Interest And Taxes | (11,613) | (11,710) | (4,080) | (19,372) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (11,613) | (11,710) | (4,080) | (19,372) | | Income Tax Expense |
-
|
-
|
-
| 300 | | Minority Interest | 2,109 | 4,501 |
-
| 59 | | | | Net Income From Continuing Ops | (5,003) | (11,710) | (4,080) | (19,613) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,003) | (11,710) | (4,080) | (19,613) | | Preferred Stock And Other Adjustments |
-
| (2,040) | 2,040 |
-
| | | Net Income Applicable To Common Shares | ($5,003) | ($13,750) | ($2,040) | ($19,613) |
|
0.11% Nasdaq 
0.01%
Income Statement
